Luxist Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Pfizer Follows Eli Lilly's Footsteps To Sell Medicines ...

    www.aol.com/pfizer-follows-eli-lillys-footsteps...

    Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand “Pfizer for All.” The move ...

  3. Eli Lilly launches website to help patients get weight loss drugs

    www.aol.com/news/eli-lilly-launches-website-help...

    Updated January 4, 2024 at 12:47 PM. Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss drug prescription through a telehealth provider — a ...

  4. Eli Lilly obesity drug now available in US pharmacies - AOL

    www.aol.com/news/eli-lillys-obesity-drug-now...

    December 5, 2023 at 9:10 AM. By Patrick Wingrove and Manas Mishra. (Reuters) -Eli Lilly on Tuesday said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and ...

  5. Eli Lilly and Company - Wikipedia

    en.wikipedia.org/wiki/Eli_Lilly_and_Company

    Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

  6. Next-generation drug from Eli Lilly boosts weight loss ... - AOL

    www.aol.com/next-generation-drug-eli-lilly...

    An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen yet ...

  7. Inovalon - Wikipedia

    en.wikipedia.org/wiki/Inovalon

    The company was founded in 1998 in Maryland as MedAssurant by Keith Dunleavy, MD. [2] In June 2012, the company changed its name to Inovalon. [3] The company publicly filed its registration statement with the Securities and Exchange Commission (SEC) on December 30, 2014 for a proposed initial public offering of its common stock and applied for ...

  8. Donanemab - Wikipedia

    en.wikipedia.org/wiki/Donanemab

    Donanemab ( USAN; development code LY3002813) is a biological drug in Phase III clinical trials to determine whether it slows the progression of early Alzheimer's disease. Donanemab has shown positive results in its first trials. [1] [2] Donanemab was developed by the Eli Lilly and Co. and is under clinical development as a possible treatment ...

  9. Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts ... - AOL

    www.aol.com/finance/eli-lillys-weight-loss-drug...

    April 30, 2024 at 11:41 AM. Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast. Tuesday, Eli Lilly And Co (NYSE: LLY ) reported first-quarter revenue of $8.77 billion, up 26% ...